Vitreoperfusion. A new approach to ocular ischemia

Area of Science:

• Ophthalmology
• Retinal Diseases
• Vascular Biology

Background:

• Retinal metabolic needs are unmet in vascular occlusion, leading to necrosis.
• Current treatments for retinal vascular occlusion are insufficient.
• Severe ischemia causes significant retinal damage.

Purpose of the Study:

• To evaluate the efficacy of vitreoperfusion in protecting the retina from severe combined retinal and choroidal ischemia.
• To assess the potential of vitreoperfusion as a treatment for ocular ischemia.

Main Methods:

• Vitreoperfusion technique involving perfusing the vitreous cavity post-vitrectomy-lensectomy with glucose and oxygen-rich fluids.
• Induction of severe ischemia by elevating intraocular pressure to 170 mm Hg in feline eyes for up to four hours.
• Histopathologic examination of retinal tissue after one week to assess damage.

Main Results:

• Untreated eyes exhibited significant retinal atrophy and dissolution.
• Eyes treated with vitreoperfusion showed no signs of retinal atrophy or dissolution.
• Demonstrated successful protection against severe, prolonged ischemia.

Conclusions:

• Vitreoperfusion effectively protected the retina against severe ischemia in a feline model.
• This technique represents a potential breakthrough for treating various forms of ocular ischemia.
• Further research is needed to optimize the technique for clinical application.